Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical 5% dapsone vs 2.5% benzoyl peroxide for acne vulgaris
TCTR20250908003Phase 3Completed
- Sponsor
- Faculty of Medicine, Srinakharinwirot University
- Start
- Feb 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dapsone, benzoyl peroxide in acne vulgaris, sponsored by Faculty of Medicine, Srinakharinwirot University. Started Feb 2024; status: completed.
02
Drugs
dapsonebenzoyl peroxide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on TCTR20250908003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250908003.